FDA PMA Approved 🇺🇸 United States

PMA: P980035 · Supplement: S002 · Decision Aug 9, 1999
Classifications
0
FEI Numbers
0
Registration Numbers
0

Basic Information

Trade Name
MEDTRONIC SIGMA SERIES PULSE GENERATORS AND MODEL 9963/A SOFTWARE
PMA Number
P980035
Supplement Number
S002
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
August 9, 1999
Date Received
March 10, 1999
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Sigma family of pulse generators & software. The DR & SR series are indicated for rate adaptive pacing in pts who may benefit fr increased pacing rates concurrent w/increases in activity. The DR & D Series, SR & S Series, & VVI series are indicated for accepted pt conditions warranting chronic cardiac pacing which include:Symptomatic paroxysmal or permanent second- or third-degree AV block; Symptomatic bilateral bundle branch block; Symptomatic paroxysmal or transient sinus node dysfunctions w/or w/o associated AV conduction disorders; Bradycardia-tachycardia syndrome to prevent symptomatic bradycardia or some forms of symptomatic tachyarrhythmias.The DR & D series pacemakers are also indicated for dual chamber & atrial tracking modes in pts whomay benefit fr maintenance of AV synchrony.Dual chamber modes are specifically indicated for treatment of conduction disorders that require restoration of both rate & AV synchrony, which include:Various degrees of AV block to maintain the atrial contribution to cardiac output; VVI intolerance (e.g., pacemaker syndrome) in the presence of persistent sinus rhythm. The pulse generator, Medtronic.Sigma(TM) Model SVDD303 Pulse Generator is indicated for the following: accepted patient conditions warranting chronic cardiac pacing which includes: Symptomatic paroxysmal or permanent second- or third-degree AV block; Symptomatic bilateral bundel branch block. These pacemakers are also indicated for dual chamber & atrial tracking modes in pts who may benefit from maintenance of AV synchrony. Dual chamber modes are specifically indicated for treatment of conduction disorders that require restoration of both rate & AV synchrony, which include: various degrees of AV block to maintain the atrial contribution to cardiac output; VVI intolerance (e.g., pacemaker syndrome) in the presence of persistent sinus rhythm. The VDD Series pacemakers are also indicated for VDD modes in pts having adequae atrial rates & various indications.